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ABSTRACT
Introduction Rheumatic heart diseases (RHDs) contribute 
significant morbidity and mortality globally. To reduce the 
burden of RHD, timely initiation of secondary prophylaxis is 
important. The objectives of this study are to determine the 
frequency of subclinical RHD and to train a deep learning 
(DL) algorithm using waveform data from the digital 
auscultatory stethoscope (DAS) in predicting subclinical 
RHD.
Methods and analysis We aim to recruit 1700 children 
from a group of schools serving the underprivileged over 
a 12- month period in Karachi (Pakistan). All consenting 
students within the age of 5–15 years with no underlying 
congenital heart disease will be eligible for the study. We 
will gather information regarding sociodemographics, 
anthropometric data, history of symptoms or diagnosis 
of rheumatic fever, phonocardiogram (PCG) and 
electrocardiography (ECG) data obtained from DAS. 
Handheld echocardiogram will be performed on each 
study participant to assess the presence of a mitral 
regurgitation (MR) jet (>1.5 cm), or the presence of aortic 
regurgitation (AR) in any view. If any of these findings are 
present, a confirmatory standard echocardiogram using 
the World Heart Federation (WHF) will be performed to 
confirm the diagnosis of subclinical RHD. The auscultatory 
data from digital stethoscope will be used to train the 
deep neural network for the automatic identification 
of patients with subclinical RHD. The proposed neural 
network will be trained in a supervised manner using 
labels from standard echocardiogram of the participants. 
Once trained, the neural network will be able to 
automatically classify the DAS data in one of the three 
major categories—patient with definite RHD, patient 
with borderline RHD and normal subject. The significance 
of the results will be confirmed by standard statistical 
methods for hypothesis testing.
Ethics and dissemination Ethics approval has been 
taken from the Aga Khan University, Pakistan. Findings 
will be disseminated through scientific publications and to 
collaborators.
Article focus This study focuses on determining the 
frequency of subclinical RHD in school- going children in 
Karachi, Pakistan and developing a DL algorithm to screen 
for this condition using a digital stethoscope.
INTRODUCTION
Rheumatic heart disease (RHD) is a serious 
complication of childhood acute rheumatic 
fever, that develops following an abnormal 
immune response to a beta- haemolytic strepto-
coccal pharyngitis infection.1 If left untreated, 
patients are at risk of established valvular lesions 
and eventual heart failure.2 Globally, RHD 
contributes to significant cardiovascular disease 
burden and mortality, particularly in low/
middle- income countries (LMICs).3 It is esti-
mated that approximately 319 400 deaths occur 
annually due to RHD, with an approximated 
morbidity of 10.5 million disability- adjusted life- 
years.1 4 Pakistan ranks among the top three 
countries that contribute to the highest esti-
mated numbers of RHD- related deaths at 18 900 
deaths annually, only to be preceded by India 
and China.1 In Pakistan, the reported preva-
lence of RHD ranges from as low as 6/1000 
population in adults to 22/1000 population 
in school- going children due to differences in 
screening protocols used.5 6 However, the true 
global burden of RHD still remains undeter-
mined due to the lack of sensitive screening 
Strengths and limitations of this study
 ► This study will be the first in Pakistan to develop a 
deep learning algorithm on phonocardiogram and 
electrocardiogram waveform data from the digi-
tal stethoscope to screen for subclinical rheumatic 
heart disease.
 ► To detect the frequency of subclinical rheumatic 
heart disease, all study participants will be screened 
using handheld echocardiograms and those with 
positive findings will have a confirmatory standard 
echocardiogram to ensure accurate diagnosis.
 ► Study participants will be selected from one group of 
schools. However, the demographics of this school 
group are generalisable to the larger population of 
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criteria.7 With the updated 2012 WHFcriteria for echocar-
diographic diagnosis of RHD, there is evidence to support 
that the RHD burden is higher than previously recorded.7
In LMICs, many communities are exposed to recur-
rent group A streptococcal infections due to increasing 
urbanisation and overcrowding.3 These often untreated 
infections lead to repeated insults to the cardiac valves, 
further enhancing valvular dysfunction. Early diagnosis 
of valvular damage in susceptible populations is funda-
mental in providing timely prophylaxis and preventing 
further cardiac morbidity.2 Cost–effective analysis of 
RHD prevention strategies shows that echocardiographic 
screening and secondary prophylaxis using penicillin is 
the best strategy to ensure cost- effective care to the indi-
vidual as well as its impact on the healthcare system.8 
The incremental cost- effectiveness ratio which compares 
cost with quality- adjusted life- years was approximately 
US$15.39 for echocardiography and prophylaxis for indi-
viduals with RHD as compared with throat swab and anti-
biotic treatment which would cost US$266.39.8
Traditional screening and diagnosis
Echocardiography has been proposed as the first- line 
screening tool for RHD. The prevalence of RHD detected by 
echocardiogram screening has been shown to be 5–10 times 
higher as compared with those by clinical examination.9 10 
In a recent systematic review by Roberts KV et al, the pooled 
prevalence of RHD detected by cardiac auscultation was 2.9 
per 1000 (95% CI 1.7 to 5.0) while with echocardiography, 
this number increased to 12.9 per 1000 people (95% CI 0.9 
to 18.6).11 Despite its accuracy, standard echocardiograms 
are costly and require specially trained staff, making it an 
impractical choice to use for mass screening of subclinical 
RHD.12 Recent studies have investigated the use of the hand-
held echocardiography device, a relatively low- cost machine 
that can be operated by less skilled healthcare providers, for 
the first- line screening of subclinical RHD.12 The criterion 
for subclinical RHD screening using handheld echocardiog-
raphy is MR jet length of ≥1.5–2.0 cm or the presence of AR 
in the anterior view across several studies.12 The sensitivity 
for borderline and/or definite RHD varied from 73% to 
78.9% and the specificity ranged between 82.4% and 87.3%. 
Further, the sensitivity for definite cases of RHD was approxi-
mately 98% in both studies evaluating handheld echocardio-
gram criteria.12 13 Despite the evidence to support handheld 
echocardiogram screening, no literature is available on its 
implementation in Pakistan.
Mass screening tool using artificial intelligence
DASlinked to smartphone- based applications help 
augment cardiac sounds and provide PCG and ECG wave-
form data.14 PCG, one of the earliest technical approaches 
for medical signal analysis, is a fundamental method for 
diagnosing a variety of cardiovascular disorders, such as 
coronary heart disease, hypertension and arrhythmia.15 
Although measuring different physical quantities, both 
an ECG and a PCG are sequential measurements of heart 
activity used to distinguish normal from abnormal heart 
function.16 Rijuven i2Dtx Cardio Sleeve is a DAS that 
has achieved a specificity of 94% and a sensitivity of 91% 
in detecting murmurs.14 These relatively user- friendly 
and cost- effective stethoscopes make for an ideal tool 
in the mass screening of subclinical RHD. Furthermore, 
machine learning algorithms trained on data from DAS 
may potentially facilitate in the detection of subclinical 
RHD without the need for echocardiography, thus iden-
tifying the population that may benefit from secondary 
prophylaxis of RHD.
To achieve the automatic classification of ECG and PCG 
signals, several approaches have been proposed using 
classic signal processing techniques, including the Fourier 
transform,17 principle component analysis,18 wavelet trans-
form19 and the hidden Markov method.20 In addition, 
some machine learning methods, such as artificial neural 
networks,21 support vector machines (SVMs),22 least squares 
SVMs23 and extreme learning machines,24 have also been 
developed for signal classification. However, these methods 
have some limitations such as requirements for large 
amount of prior knowledge, manual features selection, and 
high computational time and complexity.25 Recently, convo-
lutional neural networks (CNNs) have proven to be a useful 
tool in signal and data classification applications.26 They 
are inspired by biological neural networks, thus making 
CNN- based methods superior in pattern recognition, classi-
fication and learning signal structure. In biomedical applica-
tions, CNN- based methods have been used for classification 
in skin cancer,27 electromyography signal classification28 
and ECG classification reference.27 Chowdhury et al used a 
simple long short- term memory (LSTM) network for ECG 
and PCG classification.27 The LSTMs are a type of recurrent 
neural networks (RNNs) that are capable of learning and 
detecting long- term dependencies in the input data.25 The 
RNNs are different from the traditional neural networks as 
they have an internal state that represents context informa-
tion by storing past input information, thus providing an 
advantage in classification and prediction tasks. In current 
advanced technology era, artificial intelligence (AI)- based 
mass screening tool can act as a bridge to reduce the gap 
between standard clinical auscultation and echocardiog-
raphy in resource- limited settings.
Hence, the objectives of this study are (1) to determine 
the frequency of subclinical RHD in school- going chil-
dren in Karachi, Pakistan and (2) to train a deep learning 
algorithm to predict subclinical RHD using auscultatory 
waveform data from the digital stethoscope.
METHODS
Study design setting and population
This will be a cross- sectional study conducted in a group 
of schools in Karachi (Pakistan). The group runs schools 
on charity basis and caters to children from low socioeco-
nomic families.
Eligibility criteria
We will include children between the ages of 5 and 15 
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(CHD) or CHD detected during echocardiogram 
performed during the study will be excluded.
Sample size calculation
According to Watkins et al, the mean standardised preva-
lence of RHD found in South Asia is 11/1000.1 Using this 
prevalence, and assumptions of 90% statistical power, 5% 
level of significance and half of the width of the stated CI 
as precision, a sample size of 1669 was calculated using the 
Open Epi sample size calculator. To account for possible 
dropouts during the study, we will enrol 1700 children.
Research assistants’ training
A workshop will be conducted by investigators to train the 
research staff on the study questionnaires, obtaining data 
from the DAS and performing echocardiograms using 
the HAND criteria.
Recruitment
The selection of students will be based on random 
sampling.
The trained research assistants (RAs) will screen chil-
dren during non- instruction school hours. An estimated 
8–10 children will be evaluated per day throughout 
the 6- day school week. To ensure patient privacy, each 
student will be screened individually, and only female 
RAs will be allowed to examine female students. 
Limited exposure of the precordium will be required, 




This will include age in years, school grade, address, 
gender, weight in kilogram, height in centimetres, heart 
rate per minute, systolic and diastolic blood pressure (mm 
Hg) by sphygmanometer one reading at start of screening 
and temperature in centigrade (°C).
DAS auscultation protocol
The RAs will perform the DAS examination consisting of 
auscultation over four sites: the right (aortic valve area) 
and left (pulmonary valve area) upper parasternal area 
at second intercostal space, the apex of the heart (mitral 
valve) at left fifth intercostal space, mid- clavicular line 
and left lower parasternal area at fourth intercostal space 
(tricuspid valve).
The PCG and ECG data obtained from the DAS will 
be uploaded on a smartphone- based app using a unique 
study ID.
Box 1 Handheld echocardiography screening protocol
Parasternal long axis view
1. Clip 2D image; zoom on mitral valve and aortic valve.
2. Place colour box on mitral valve only and pan through valve. Clip to 
show most presence of MR.
3. Measure the maximum jet length from point of vena contracta to 
end.
4. Place colour box on aortic valve only and pan through valve. Clip to 
show most presence of AR.
Apical four- chamber view
1. Clip 2D image, place focus at valve level.
2. Place colour box on mitral valve and pan through valve. Clip to show 
most presence of MR.
3. Measure the maximum jet length from point of vena contracta to 
end.
Apical five- chamber view
1. Clip 2D image; may zoom on left ventricular outflow tract (LVOT) or 
narrow sector to only visualise LVOT.
2. Place colour box on aortic valve and pan through valve. Clip to show 
most presence of AR.
Figure 1 Paired standard/handheld echocardiographic images. With permission to reproduce from Elsevier publisher (https://
doi.org/10.1016/j.echo.2013.09.013). Paired standard/handheld echocardiographic images in patients with rheumatic heart 
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Following auscultation, screening echocardiography 
will be performed using GE Vscan. Protocol for views 
and frames is specified in box 1 according to handheld 
criterion.13 Cases with MR jet >1.5 cm, or the presence of 
AR in any view will be labelled as suspected subclinical 
RHD and eligible for further screening through standard 
echocardiography.
Standard echocardiography
The suspected subclinical RHD cases on handheld echo-
cardiography will undergo standard echocardiography by 
a paediatric cardiologist on Vivid iq machine (GE Health-
care, Chicago Illinois, USA). For echocardiography, 
machine settings following Nyquist limits for colour 
Doppler echocardiography will be set on maximum to 
avoid overestimation of jet length. Images for assessment 
of valvular and chordal thickness will be acquired with 
harmonics turned off and probes with variable frequency 
set on ≥2.0 MHz. Gain settings will be adjusted to achieve 
optimal resolution. All other settings (including depth, 
sector size and focus) will be optimised to achieve 
maximal frame rate (ideally 30–60 frames per second) 
and resolution.28 Borderline and definite RHD will be 
decided based on WHF criteria (online supplemental file 
1) (figure 1). Protocol for views and frames for standard 
echocardiogram has been specified in box 2.
Deep learning protocols
In this study, we will use the deep neural networks, that 
is, fully connected LSTMs (FC- LSTMs) and convolution 
LSTMs (Conv- LSTMs), for the data classification task. 
These deep learning networks typically require fixed 
dimension inputs. In case of sequential data, such as 
PCG, a sequence- to- sequence autoencoder will be used 
in training and learning stages to create same size inputs. 
The classification algorithms will be employed on ECG, 
PCG and on their hybrid version (ECG +PCG). We will 
use a simple network architecture where a single input 
neuron connected to the input signal will use several 
hidden layers of LSTMs. These hidden layers extract the 
signal features for classification and are connected with 
the output layer. The squared error of the output layer 
activation will be used as objective function for the result 
validation (figure 2).
Quality control
To assess proper conduction and interpretation of echo-
cardiograms and DAS auscultation, a paediatric cardiolo-
gist will observe the RAs for the initial days of screening 
and will check all images weekly.
For suspected subclinical RHD cases which undergo 
standard echocardiography, two trained paediatric cardi-
ologists will independently review the echocardiography 
to confirm the diagnosis.
Confirmed cases with subclinical RHD will be referred 
to a cardiologist for further management. Those children 
who will need financial assistance will get support from a 
previously established endowment CHD fund.
The study flow diagram has been detailed in figure 3.
Data analysis plan
Data analysis will be performed using SPSS V.20.0. Data 
will be reported as percentages and means±SD where 
appropriate. The frequency of borderline and definite 
RHD will be calculated based on true positive (TP) cases 
diagnosed on standard echocardiography.
The significance of the results will be confirmed using 
standard hypothesis testing methods, such as analysis of 
variance (ANOVA) or multivariate ANOVA to compute 
p value and/or f value. These two values will decide if 
the null hypothesis should be rejected. In this study, an 
Box 2 Standard echocardiography protocol
Parasternal long axis view
1. Clip 2D image; zoom on mitral valve and aortic valve.
2. Place colour box on mitral valve only and pan through valve. Clip to 
show most presence of MR.
3. Through calliper, measure MR jet length from point of vena contrac-
ta until end.
4. Through calliper, measure maximum thickness of anterior mitral 
valve leaflet.
5. Place colour box on aortic valve only and pan through valve. Clip to 
show most presence of AR.
6. In the presence of AR, perform M- mode through aortic valve with 
colour on to show presence of AR in systole.
Parasternal short axis view
1. Clip 2D of short axis image at level of mitral valve.
2. Place colour box on mitral valve orifice and clip to show where MR 
is originating.
Apical four- chamber view
1. Clip 2D image, place focus at valve level.
2. Turn on tissue velocity imaging (TVI), turn off visibility and clip im-
age—ensure that sector begins at the tip of the sector and includes 
entire heart.
3. Place colour box on mitral valve and pan through valve. Clip to show 
most presence of MR.
4. Pulse wave (PW) mitral valve inflow.
5. Continous wave (CW) doppler on mitral valve to include any 
regurgitation.
6. Tissue Doppler lateral free wall of left ventricle (LV).
7. Tissue Doppler medial septum of LV.
8. Decrease depth to mid- atria and focused on image quality of both 
the LV and right ventricle (RV)—ensure that frame rate is above 50 
or greater or equal to heart rate, clip 2D image.
9. Through calliper, measure MR jet length from point of vena contrac-
ta until end.
Apical five- chamber view
1. Clip 2D image; may zoom on left ventricular outflow tract (LVOT) or 
narrow sector to only visualise LVOT.
2. Place colour box on aortic valve and pan through valve. Clip to show 
most presence of AR.
3. PW LVOT.
4. CW doppler on aortic valve, take additional clip with doppler base-
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FC- LSTM or Conv- LSTM is employed as a tool for distin-
guishing between a normal patient and patient with RHD. 
The evaluation will be performed with a confusion matrix 
which predicts the model performance by comparing the 
model prediction against the true values. The confusion 
matrix is a 2×2 matrix, contains TP, true negative (TN), 
false positive (FP) and false negative (FN) values. The TP 
and TN values represent the correctly predicted classifi-
cations, while FP and FN values represent the incorrectly 
predicted classifications. An example of confusion matrix 
is given in online supplemental file 2.
Using the confusion matrix, we can calculate different 
parameters for evaluation. In our case, the two interesting 
parameters are the sensitivity and the specificity. The 
sensitivity, also called the TP rate (TPR), represents how 
well the classifier predicts the patients with RHD correctly, 
giving the input ECG and PCG data. The specificity indi-
cates how well the classifier predicts normal patients. 
With an optimised classifier, the goal is to achieve high 
sensitivity and specificity. For a given classifier, the sensi-








In addition, we will also use the receiver operating 
characteristic (ROC) curve, which is a graphical plot to 
analyse a binary classifier performance, and area under 
the curve (AUC) value for the classifier evaluation. The 
ROC curve uses the TPR and FP rate (FPR), these rates 
are then plotted against each other together with a refer-
ence line. The AUC value is calculated from the TPR and 
FPR and is between 0 and 1 which represents the area 
under the ROC curve. A high AUC (closer to 1) implies a 
good performing classifier, while a low AUC (below 0.5) 
indicates worse than randomly guessing.
Potential impact
From a public health perspective, determining the 
frequency of subclinical RHD in children is an essen-
tial step to estimate the burden of disease at an early 
stage and initiate the enforcement of secondary prophy-
laxis. Increased emphasis is required for early detection 
of subclinical RHD, which can be facilitated through 
Figure 2 Deep learning schematic diagram. Deep learning model using long short- term memory (LSTM) and its variant, 
convolution LSTMs and fully connected LSTMs. PCG, phonocardiogram; RHD, rheumatic heart disease.
Figure 3 Study flow diagram. DAS, digital auscultatory 
stethoscope; DL, deep learning; RAs, research assistants; 
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handheld devices such as the DAS along with machine 
learning algorithms to screen young children, without 
the need for community- based echocardiography. If 
implemented on a larger scale, these screening tools 
could revolutionise the detection and treatment of RHD 
within communities and improve disease outcomes.
Patient and public involvement
RHD is a fairly common problem at our part of world, 
majority of patients who have suffered in this lesion 
belong to poor- resource setting that not only means lack 
of financial support and disease awareness but access 
to care as well. All these factors not only contribute in 
repeated bouts of rheumatic fever leading to significant 
RHD. Detection of patients who have had an episode 
of rheumatic fever and have subclinical RHD provides 
the best window for prevention of advanced RHD by 
providing prophylaxis against repeated streptococcal 
infection. Detection of this stage on clinical auscultation 
is not reliable as cases are missed. Echocardiography is the 
gold standard but not a feasible solution for screening at 
population level. Despite adequate counselling in outpa-
tient visit, the financial constraints and lack of access are 
major hurdles to patient’s compliance for follow- up. On 
basis of these observations, we developed our research 
proposal to develop an AI algorithm by using waveform 
data of digital stethoscope to detect subclinical RHD. 
This will allow for screening in school. Our study popula-
tion includes school- going children rather than patients 
with established RHD to detect subclinical RHD. Before 
enrolment in this study, informed consent or assent will 
be taken after explaining the purpose of the study and we 
will also provide the assurance to patients/parents that 
study finding will be confidential and disseminated to 
parents/patients directly by the physician and in case of 
findings of RHD, children will be referred to the cardiol-
ogist for further evaluation.
Contributors FA, BH and DC have contributed equally to the study concept, 
designing and developing the protocol. FA, HA and ZB have contributed to 
protocol writing. ZH contributed to methodology and statistical writing. MH and SA 
contributed to machine learning, designing the methods on how waveform data will 
be processed.
Funding This study was funded by the Aga Khan University, University Research 
Council grant (URC grant 191003).
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has 
not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been 
peer- reviewed. Any opinions or recommendations discussed are solely those 
of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and 
responsibility arising from any reliance placed on the content. Where the content 
includes any translated material, BMJ does not warrant the accuracy and reliability 
of the translations (including but not limited to local regulations, clinical guidelines, 
terminology, drug names and drug dosages), and is not responsible for any error 
and/or omissions arising from translation and adaptation or otherwise.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY- NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non- commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non- commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
ORCID iDs
Fatima Ali http:// orcid. org/ 0000- 0001- 8899- 7826
Zahra Hoodbhoy http:// orcid. org/ 0000- 0002- 0439- 8293
REFERENCES
 1 Watkins DA, Johnson CO, Colquhoun SM, et al. Global, regional, 
and national burden of rheumatic heart disease, 1990-2015. N Engl J 
Med 2017;377:713–22.
 2 Sika- Paotonu D, Beaton A, Raghu A, et al. Acute Rheumatic Fever 
and Rheumatic Heart Disease. In: Ferretti JJ, Stevens DL, Fischetti 
VA, eds. Streptococcus pyogenes : Basic Biology to Clinical 
Manifestations. Oklahoma City (OK: University of Oklahoma Health 
Sciences Center, 2016.
 3 Carapetis JR, Steer AC, Mulholland EK, et al. The global burden of 
group A streptococcal diseases. Lancet Infect Dis 2005;5:685–94.
 4 Fever WHOSGoR, Rheumatic Heart D, World Health O. Rheumatic 
fever and rheumatic heart disease : report of a WHO expert 
consultation, Geneva, 20 October - 1 November 2001. Geneva World 
Health Organization. 2004.
 5 Rizvi SF, Khan MA, Kundi A, et al. Status of rheumatic heart disease 
in rural Pakistan. Heart 2004;90:394–9.
 6 Remenyi B, Carapetis J, Wyber R, et al. Position statement of the 
world heart Federation on the prevention and control of rheumatic 
heart disease. Nat Rev Cardiol 2013;10:284–92.
 7 Rothenbühler M, O'Sullivan CJ, Stortecky S, et al. Active surveillance 
for rheumatic heart disease in endemic regions: a systematic review 
and meta- analysis of prevalence among children and adolescents. 
Lancet Glob Health 2014;2:e717–26.
 8 Manji RA, Witt J, Tappia PS, et al. Cost- Effectiveness analysis 
of rheumatic heart disease prevention strategies. Expert Rev 
Pharmacoecon Outcomes Res 2013;13:715–24.
 9 Sadiq M, Islam K, Abid R, et al. Prevalence of rheumatic heart 
disease in school children of urban Lahore. Heart 2009;95:353–7.
 10 Reeves BM, Kado J, Brook M. High prevalence of rheumatic heart 
disease in Fiji detected by echocardiography screening. J Paediatr 
Child Health 2011;47:473–8.
 11 Roberts KV, Brown ADH, Maguire GP, et al. Utility of auscultatory 
screening for detecting rheumatic heart disease in high- risk children 
in Australia's Northern Territory. Med J Aust 2013;199:196–9.
 12 Lu JC, Sable C, Ensing GJ, et al. Simplified rheumatic heart disease 
screening criteria for handheld echocardiography. J Am Soc 
Echocardiogr 2015;28:463–9.
 13 Ploutz M, Lu JC, Scheel J, et al. Handheld echocardiographic 
screening for rheumatic heart disease by non- experts. Heart 
2016;102:35-9.
 14 Kocharian A, Sepehri A- A, Janani A, et al. Efficiency, sensitivity and 
specificity of automated auscultation diagnosis device for detection 
and discrimination of cardiac murmurs in children. Iran J Pediatr 
2013;23:445–50.
 15 , Mozaffarian D, Benjamin EJ, Go A, et al, Writing Group Members. 
Executive Summary: Heart Disease and Stroke Statistics--2016 
Update: A Report From the American Heart Association. Circulation 
2016;133;): :447–54. vol..
 16 Joyanta Kumar Roy Tsr, Subhas Chandra Mukhopadhyay. heart 
sound: detection and analytical approach towards diseases. Modern 
Sensing Technologies 2019:103–45.
 17 Chauhan S, Wang P, Sing Lim C, et al. A computer- aided MFCC- 
based HMM system for automatic auscultation. Comput Biol Med 
2008;38:221–33.
 18 Abdi H, Williams LJ. Principal component analysis. WIREs Comp Stat 
2010;2:433–59.
 19 Li C, Zheng C, Tai C. Detection of ECG characteristic points using 
wavelet transforms. IEEE Trans Biomed Eng 1995;42:21–8.
 20 Coast DA, Stern RM, Cano GG, et al. An approach to cardiac 
arrhythmia analysis using hidden Markov models. IEEE Trans Biomed 
Eng 1990;37:826–36.
 21 Yang J, Singh H, Hines EL, et al. Channel selection and classification 
of electroencephalogram signals: an artificial neural network and 
genetic algorithm- based approach. Artif Intell Med 2012;55:117–26.
 22 Quitadamo FC LR, Sbernini L, et al. Support vector machines to 
detect physiological patterns for EEG and EMG- based human–

















pen: first published as 10.1136/bm





7Ali F, et al. BMJ Open 2021;11:e044070. doi:10.1136/bmjopen-2020-044070
Open access
 23 Lima CAM, Coelho ALV, Eisencraft M. Tackling EEG signal 
classification with least squares support vector machines: a 
sensitivity analysis study. Comput Biol Med 2010;40:705–14.
 24 Ding S, Zhang N, Xu X, et al. Deep extreme learning machine and 
its application in EEG classification. Mathematical Problems in 
Engineering 2015;2015:1–11.
 25 Bengio Y, Courville A, Vincent P. Representation learning: a 
review and new perspectives. IEEE Trans Pattern Anal Mach Intell 
2013;35:1798–828.
 26 Kim Y. Convolutional neural networks for sentence classification. 
In Proceedings of the 2014 Conference on Empirical Methods in 
Natural Language Processing (EMNLP), Doha, Qatar. Association for 
Computational Linguistics, 2014:1746–51.
 27 Chowdhury MEH, Khandakar A, Alzoubi K, et al. Real- Time Smart- 
Digital stethoscope system for heart diseases monitoring. Sensors 
2019;19. doi:10.3390/s19122781. [Epub ahead of print: 20 Jun 
2019].
 28 Reményi B, Wilson N, Steer A, et al. World heart Federation criteria 
for echocardiographic diagnosis of rheumatic heart disease—an 
















pen: first published as 10.1136/bm
jopen-2020-044070 on 5 A
ugust 2021. D
ow
nloaded from
 
